EBITDA
Displaying items 5441-5460 of 5830 in total
Bluerock’s $150M SPAC: A New Blank Check for Critical Minerals?
Data Over Drugs: How a Biomarker Reshaped Breast Cancer Care
KT&G's Perfect ESG Score: A New Standard or a Paradox?
Beyond the Bailout: Turning Farm Innovation into Sustainable Cash Flow
FC Supra’s Homegrown Playbook: A New Brand Blueprint for Quebec
Emeren Solar Goes Private in Strategic Move to Navigate Energy Race
NOV's Nuclear Gambit: Powering the AI Revolution with Oilfield Muscle
Serina's FDA Gambit: More Than a Parkinson's Drug Is on the Line
Gemini's Prediction Market Win: A New Crypto Era or a Risky Bet?
Match Group's AI Gambit: Hinge's New Era and the Overtone Spinout
Atlanticus Secures Major Refinancing, Signals Post-Merger Strength
Darling Forges a $1.5B Collagen Giant to Capture the Wellness Boom
AllianceBernstein's $3B Outflow: A Crack in the Institutional Wall?
Ryman's Dual Bet: What to Watch in its Hospitality & Music Earnings
McGraw Hill's Debt Diet: How Financial Discipline Fuels EdTech Ambition
Nordson's Precision Edge: Investing in the Unseen Luxury Tech
RYAM at a Crossroads: CEO Retirement Puts 'BioFuture' Vision to the Test
GRI Bio's IPF Drug Shows Potential to Repair Lung, Not Just Slow Damage
T1 Energy Seeks $260M to Fund US Solar Gigafactory, Meet Regulations
